Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 23 4 2020
medline: 20 5 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

Cancer affects up to 20% of critically ill patients, and sepsis is one of the leading reasons for ICU admission in this setting. Early signals suggested that survival might be increasing in this population. However, confirmation studies have been lacking. The goal of this study was to assess trends in survival rates over time in cancer patients admitted to the ICU for sepsis or septic shock over the last 2 decades. Seven European ICUs. A hierarchical model taking into account the year of admission and the source dataset as random variables was used to identify risk factors for day 30 mortality. Data from cancer patients admitted to ICUs for sepsis or septic shock were extracted from the Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique database (1994-2015). Overall, 2,062 patients (62% men, median [interquartile range] age 59 yr [48-67 yr]) were included in the study. Underlying malignancies were solid tumors (n = 362; 17.6%) or hematologic malignancies (n = 1,700; 82.4%), including acute leukemia (n = 591; 28.7%), non-Hodgkin lymphoma (n = 461; 22.3%), and myeloma (n = 244; 11.8%). Two-hundred fifty patients (12%) underwent allogeneic hematopoietic stem cell transplantation and 640 (31.0%) were neutropenic at ICU admission. Day 30 mortality was 39.9% (823 deaths). The year of ICU admission was associated with significant decrease in day 30 mortality over time (odds ratio, 0.96; 95% CI, 0.93-0.98; p = 0.001). Mechanical ventilation (odds ratio, 3.25; 95% CI, 2.52-4.19; p < 0.01) and vasopressors use (odds ratio, 1.42; 95% CI, 1.10-1.83; p < 0.01) were independently associated with day 30 mortality, whereas underlying malignancy, allogeneic hematopoietic stem cell transplantation, and neutropenia were not. Survival in critically ill oncology and hematology patients with sepsis improved significantly over time. As outcomes improve, clinicians should consider updating admission policies and goals of care in this population.

Identifiants

pubmed: 32317596
doi: 10.1097/CCM.0000000000004322
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

822-829

Commentaires et corrections

Type : CommentIn

Auteurs

Virginie Lemiale (V)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Stéphanie Pons (S)

U976, INSERM, Paris, France.

Adrien Mirouse (A)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Jean-Jacques Tudesq (JJ)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Yannick Hourmant (Y)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Djamel Mokart (D)

Critical Care Department, Institute Paoli-Calmettes, Marseille, France.

Frédéric Pène (F)

Medical ICU, Cochin Teaching Hospital, Paris, France.

Achille Kouatchet (A)

Medical ICU, Angers Teaching Hospital, Angers, France.

Julien Mayaux (J)

Respiratory and Medical ICU, University Hospitals Pitié Salpêtrière - Charles Foix, Paris, France.

Martine Nyunga (M)

ICU, Roubaix Hospital, Roubaix, France.

Fabrice Bruneel (F)

ICU, André Mignot Hospital, Le Chesnay, France.

Anne-Pascale Meert (AP)

ICU, Institute Jules Bordet, Bruxelles, Belgium.

Edith Borcoman (E)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Magali Bisbal (M)

Critical Care Department, Institute Paoli-Calmettes, Marseille, France.

Matthieu Legrand (M)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Dominique Benoit (D)

ICU, Ghent University Hospital, Gent, Belgium.

Elie Azoulay (E)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Michaël Darmon (M)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.

Lara Zafrani (L)

Medical ICU, Saint-Louis Teaching Hospital, Paris, France.
U976, INSERM, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH